News Conference News PCR London Valves 2024 Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia Michael O'Riordan November 26, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Daily News Acute HF Patients Live Longer When Seen by Specialists Michael O'Riordan August 09, 2024
News Daily News PCI Complications Portend Dire Outcomes: Tracking Could Be Key Caitlin E. Cox July 25, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2024 Shelley Wood July 02, 2024
News Daily News Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage Todd Neale June 28, 2024
News Daily News Knowns and Unknowns in Subclinical Aortic Valve Thrombosis Caitlin E. Cox June 21, 2024
News Conference News ESC Heart Failure 2024 Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show Michael O'Riordan May 21, 2024
News Daily News HeartMate 3 Recalled for Risk of Blood Leaks or Air in System L.A. McKeown May 15, 2024
News Daily News TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction Michael O'Riordan May 06, 2024
News Daily News HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction Caitlin E. Cox April 22, 2024
News Conference News ACC 2024 Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It Michael O'Riordan March 27, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News New Risk Score Better for Capturing Medical Urgency for Heart Transplantation Michael O'Riordan February 19, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024